key: cord-0728854-2l1mtdwq authors: Ravetti, Cecilia Gómez; Vassallo, Paula Frizera; de Barros, Guilherme Monteiro; Rocha, Guilherme Carvalho; Chamon, Samuel; Borges, Isabela Nascimento; Marinho, Carolina Coimbra; Cabral, Máderson Alvares de Souza; Duani, Helena; de Andrade, Marcus Vinícius Melo; Nobre, Vandack title: Lung ultrasound can predict the clinical course and the severity of COVID-19 disease date: 2021-05-03 journal: Ultrasound Med Biol DOI: 10.1016/j.ultrasmedbio.2021.04.026 sha: bc244a4255a7ff45d59dcdd38726b9afaedaa6da doc_id: 728854 cord_uid: 2l1mtdwq COVID-19 disease compromises the lung in large numbers of patients. The development of minimally invasive methods to determine the severity of the pulmonary extension is requested. This study aimed to describe the characteristics of sequential lung ultrasound and to test the prognostic usefulness of this exam in a group of patients admitted with COVID-19. We prospectively evaluated patients with SARS-CoV-2 infection admitted to our hospital between April and August 2020. Bedside lung ultrasound (LUS) exams were performed in three-times points: inclusion (D1), after 48 hours (D3), and on the seventh day of follow-up (D7). Lung ultrasound scores were quantified according to the aeration loss in each of 8 zones scanned. Sixty-six patients were included, 42 (63.6%) in the ICU and 24 (36.3%) in the ward. The LUS scores were higher in patients admitted to the ICU than those admitted to the ward on the inclusion (16 [13-17] vs 10 [4-14], p <0.001), after 48h (15.5 [13-17] vs 12.5 [8.2-14.7], p=0.001), and on the seventh day (16 [14-17] vs 7 [4.5 -13.7], p<0.001) respectively. The LUS score measured on the time of inclusion in the study was independently associated with the need for ICU admission (OR=1.480; 95%CI: 1.093-2.004, p=0.011) adjusted by the Sequential Organ Failure Assessment (SOFA) score. The SARS-CoV-2 infection was first described in China in December 2019 and rapidly spread worldwide. Today, COVID-19, the disease caused by a new beta coronavirus affects more than 37 million people around the world, and more than one million have died (Organization. 2020). COVID-19 diagnosis requires the RNA isolation from clinical samples or a high clinical suspicion associated with typical images on chest computerized tomography, such as peripheral ground glass-opacities mainly in lower regions of the lungs (Fang, et al. 2020) . In critically ill patients, with severe hypoxemia requiring mechanical invasive ventilatory support, transport for chest imaging methods is both clinically dangerous and associated with a higher risk of virus transmission during transportation (Simpson, et al. 2020) . Bedside lung ultrasonography (LUS) has proven to be useful to evaluate COVID-19 patients, with several studies describing the main characteristics findings of this exam (Convissar, et al. 2020 , Peng, et al. 2020 , Qian-Yi 2020 ). As it is non-invasive and without ionizing radiation exposure, it is an excellent alternative to other methods for diagnosing and monitoring the pulmonary conditions of patients with suspected or confirmed COVID-19. Moreover, LUS might reduce the need for patient transport and its related risks. Recently, Lichter (Yael 2020) showed that a LUS score measured at admission strongly correlates with the need for invasive mechanical ventilation and mortality in SARS-CoV-2 infected patients. In this study 120 patients were included, but only 20 were sequentially screened with a second exam. Perrone et al. also evaluated COVID-19 patients admitted to the wards and analysed fourteen windows in two times-points, admission and discharge. Fifty-two patients were included and they observed positive correlation between lung ultrasound scores (LUS) and worsening ). This study aimed to describe the characteristics of sequential LUS and to test the prognostic usefulness of this exam in a group of patients admitted in a tertiary hospital, both intensive care units and ward, with suspected COVID-19. This study was carried out at Hospital das Clínicas, Universidade Federal de Minas Gerais (HC-UFMG). We used a convenient sampling protocol to include patients admitted between April and August 2020. During this period all adults (18 years of age or older) admitted to the units dedicated to the care of COVID-19 patients (a 23-bed ward and an 18-bed intensive care unit) were assessed for potential eligibility. The exclusion criteria were the COVID-19 non-confirmation by RT-PCR (reversetranscriptase polymerase chain reaction), a more probable differential diagnosis at the time of inclusion, exclusive palliative care at the moment of first assessment for the study, and patients with a high probability of death within 24h from inclusion. The local Ethics Committee under the protocol number 30437020.9.3001.5124 approved this study, and all included patients signed an informed consent form. The first priorities to admit patients in the ICU were: hemodynamic instability with noradrenaline requirement (>0.1 mcg/kg/min), acute kidney injury (AKI) with haemodialysis requirement, endotracheal intubation for invasive mechanical ventilation, and post cardiac arrest. The second priority were patients with median arterial pressure < 65 mmHg or systolic blood pressure <90mmHg; oxygen saturation <93% in room air; pulmonary infiltration rapidly progressive (50% in 24h-48h); and NEWS (National Early Warning Score) score ≥7. Clinical and epidemiological data were prospectively collected using electronic charts. The prevalence of comorbidities such as chronic obstructive pulmonary disease, asthma, systemic arterial hypertension, heart failure, diabetes mellitus, coronary artery disease, obesity, solid organ neoplasm, hematological neoplasm, solid organ or hematopoietic stem cell transplantation, and chronic renal replacement therapy requirement was also registered. Finally, we calculated the SOFA (Vincent, et al. 1996) score for all patients included in the study, and the APACHE II (Knaus, et al. 1985) score in patients admitted to the intensive care unit. Ultrasound exams were performed in three-time points with 3 to 4 seconds image acquisition (recorded) in each area: inclusion in the study, after 48 hours, and on the seventh day after inclusion. The images were acquired by a same . The depth was adjusted between 5cm and 10cm at the beginning of the exam. In lateral areas, according to visualized costophrenic zones, some deeper images were obtained (15cm) to determine the presence of pleural effusion and consolidation. For better visualization of the pleura, a linear probe (5-10 MHz) was used whenever required. The linear probe was mainly used in order to diagnose or rule out pneumothorax or barotrauma related with mechanical ventilation. According to the images found in each assessed area, pulmonary aeration was quantified through a previously defined score (Soummer, et al. 2012 ): 0 points for A lines with lung sliding; 1 point for more than 3 well-defined B lines; 2 points for coalescent B lines; 3 points for consolidation; 1point if pleural effusion is present in each hemithorax. A "B-" w artifact, hyperechoic, dynamic line that originates in the pleural line, and move synchronously with lung sliding. A "w -defined B line pattern" was characterized by more than 3 B-lines in an intercostal space and the operator could be able to count them. "C B-lines pattern'' were characterized by B-lines that the operator could not be able to quantify them because they are so numerous and tend to merge ( Figure 2 ). The score ranged from 0 to 26 points, with higher values meaning greater loss of aeration. patients had dyspnea more frequently, had higher SOFA scores on admission, and spent more time in the hospital than patients admitted in the ward (Table 1) . LUS scores were significantly higher among patients initially admitted to the ICU as compared to those admitted to the ward; these differences were observed at inclusion, on day 3 and on day 7 (Figure 3 ). We further compared the tendency of LUS scores measured on day 1, day 3 and day 7 of follow-up between patients who initially required ICU and those admitted to the ward. There was no significant in-group difference among the pulmonary scores In an analysis adjusted for severity (ie, SOFA score), the LUS score measured on the time of inclusion in the study was independently associated with the needed for ICU admission (OR=1.480; 95%CI 1.093-2.004, p=0.011). Lung ultrasound findings stratified by the need for ICU admission. 5 ). In this study, a LUS score for pulmonary aeration loss quantified at the bedside showed to be independently associated with the need for ICU admission among patients admitted with COVID-19, adjusted by the severity. Also, sequential lung scores measured after 48 hours of inclusion (D3), and on the seventh day of follow-up (D7) were higher in patients admitted to the ICU than patients in the ward. Likewise, ICU w B ' admitted to the ward. Since the beginning of the pandemic, several studies on LUS in COVID-19 patients have been published in the medical literature , Qian Yi 2020 ). Our findings on LUS are in agreement with previously published data which showed impaired aerated predominantly in posteroinferior regions and is identified by the presence of B lines with different patterns, from well-defined B lines to "w " " k " lidations (Smith, et al. 2020 , Volpicelli, et al. 2020 , Xing, et al. 2020 ). Lichter (Lichter, et al. 2020) carried out a study with LUS in 120 COVID-19 patients. The authors performed a first exam at the time of hospital admission in all patients, and a second exam in a subgroup of twenty patients who required orotracheal intubation. This study demonstrated that the pulmonary score measured upon admission was associated with the composite outcome of need for invasive mechanical ventilation or death. These findings are in line with our results that showed a more significant loss of aeration in patients who required intensive care unit admission and died during hospitalization. Bonadia (2020) recently demonstrated in 41 patients with COVID-19 disease that in the first ultrasound exam performed at the emergency department, the rates of pathologic lung areas involved and the scores of aeration loss were higher among those who were admitted to the ICU or died during hospitalization. In accordance with our results the ultrasound showed interesting results to differentiate the severity of the disease. Our study, sequentially evaluated lung ultrasound in a larger number of COVID-19 patients, assessed at three time-points, and with different severities. We hypothesized that by doing so, we would be able to monitor the evolution of lung compromise (i.e., aeration loss) during the first week of the disease, which could help to predict the need of ICU admission and death. Our data suggest that LUS findings can be added to other clinical and laboratory data to render the decision-k ' management more accurate. In other scenarios of severe pulmonary disease, pulmonary ultrasonography has proved to be useful, both in diagnosis (Lichtenstein and Mezière 2008) and in monitoring PEEP adjustment (Bouhemad, et al. 2011 ) and the response to antibiotic treatment in cases of ventilator associated pneumonia (Bouhemad, et al. 2010) . Previous studies demonstrated the evolution of pulmonary lesions in the convalescence period, from the consolidation to A-lines patterns (Qian-Yi 2020, Xing, et al. 2020) . Using this method in a systematic protocol would avoid patients' transport for CT scan, and the exposure of health workers to chest X-ray. Moreover, in lowresource environments and remote areas such as Amazon region, LUS can be a portable alternative to help manage COVID-19 patients. Our results highlight the importance of performing a bedside lung ultrasound to determine the disease's severity and to quantify the aeration loss in patients admitted with SARS-CoV-2 infection. Another limitation was that it is a single-centre study with the inclusion of a small number of patients. However, the prospective design along with the protocol of sequential LUS images in patients admitted to the hospital with COVID-19, is a positive aspect of the study, and can contribute to anticipating the need for intensive care admission. The bedside lung ultrasound proved to be a suitable method for determining severity of LUS: bedside lung ultrasound score. Bedside ultrasound assessment of positive end-expiratory pressure-induced lung recruitment APACHE II: a severity of disease classification system Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol Lung ultrasound predicts clinical course and outcomes in COVID-19 patients CLUE: COVID-19 lung ultrasound in emergency department On the Impact of Different Lung Ultrasound Imaging Protocols in the Evaluation of Patients Affected by Coronavirus Disease 2019: How Many Acquisitions Are Needed? Expert Agreement in the Interpretation of Lung Ultrasound Studies Performed on Mechanically Ventilated Patients Lung Ultrasound for Critically Ill Patients CCUSG) CCCUSG. Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic A New Lung Ultrasound Protocol Able to Predict Worsening in Patients Affected by Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA -Secondary Publication Lung Ultrasound for COVID-19 Patchy Pneumonia: Extended or Limited Evaluations? Point-of-care lung ultrasound in patients with COVID-19 -a narrative review Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method Ultrasound assessment of lung aeration loss during a successful weaning trial predicts postextubation distress The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine What's new in lung ultrasound during the COVID-19 pandemic Lung ultrasound findings in patients with COVID-19 pneumonia Coronavirus disease 2019 (COVID-19) situation report Figure 1. Thorax ultrasound protocol regions scanned MCL: midclavicular line. AAL: anterior axillary line. PAL: posterior axillary line. SA: sternal angle. IC: iliac crest. S: scapula. A: arm Figure 2: Ultrasound lung patterns in COVID-19 Upper right: well-defined B-lines pattern (white arrows). Bottom left: coalescent B-lines Figure 3. Comparison between medians LUS scores (D1-D3-D7) according to the ICU admission requirement D1: day of inclusion. D3: 48h of inclusion. D7: seventh day of inclusion coalescent B-lines; IPL: irregular pleural line. SPC: subpleural consolidation. ICU: intensive care unit This work was support in part by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Ministério de Educação (MEC) Brasil, and Universidade Federal de Minas Gerais (UFMG). The authors declare that there is no conflict of interest regarding the publication of this paper.